KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned: 2010-2025

Historic Times Interest Earned for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to $5.03.

  • Emergent BioSolutions' Times Interest Earned fell 35.24% to $5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.99, marking a year-over-year increase of 208.68%. This contributed to the annual value of -$1.53 for FY2024, which is 81.47% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Times Interest Earned stood at $5.03, which was up 4,523.97% from $0.11 recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Times Interest Earned high stood at $31.87 for Q4 2021, and its period low was -$12.29 during Q3 2023.
  • Moreover, its 3-year median value for Times Interest Earned was -$0.64 (2024), whereas its average is -$2.19.
  • Its Times Interest Earned has fluctuated over the past 5 years, first surged by 904.18% in 2021, then tumbled by 1,284.87% in 2022.
  • Emergent BioSolutions' Times Interest Earned (Quarterly) stood at $31.87 in 2021, then plummeted by 113.56% to -$4.32 in 2022, then surged by 53.28% to -$2.02 in 2023, then surged by 68.20% to -$0.64 in 2024, then plummeted by 35.24% to $5.03 in 2025.
  • Its Times Interest Earned stands at $5.03 for Q3 2025, versus $0.11 for Q2 2025 and $3.39 for Q1 2025.